Assuntos
Manuseio das Vias Aéreas/normas , Intubação Intratraqueal/métodos , Laringoscópios , Laringoscopia/métodos , Gravação em Vídeo/instrumentação , Obstrução das Vias Respiratórias/etiologia , Procedimentos Cirúrgicos Eletivos , Humanos , Intubação Intratraqueal/instrumentação , Obesidade Mórbida/complicações , Ensaios Clínicos Controlados Aleatórios como AssuntoRESUMO
UNLABELLED: The cardiovascular effects of volatile anesthetics in prenatal hearts are not well investigated. The purpose of this study was to determine whether the embryonic cardiovascular system is sensitive to an exposure to clinically relevant, equipotent concentrations of halothane and isoflurane. Stage 24 (4-day-old) chick embryos were exposed to 0.09 and 0.16 mM of halothane and 0.17 and 0.29 mM of isoflurane. Dorsal aortic blood velocity was measured with a pulsed-Doppler velocity meter. Halothane, but not isoflurane, caused a significant decrease in cardiac stroke volume and maximum acceleration of blood (dV/dt(max)), an index of cardiac performance. This effect was reversible, and during washout, stroke volume and dV/dt(max) increased above control levels. Embryonic heart rate was not affected by either drug. Chick and human embryos are similar during early stages of development; therefore, chick embryo may be a useful model to study the cardiovascular effects of anesthetics. IMPLICATIONS: In equipotent, clinically relevant concentrations, halothane, but not isoflurane, markedly decreased aortic blood flow and cardiac performance measured with ultrasound techniques in chick embryos. Chick and human embryos are similar during early stages of development; therefore, chick embryo may be a useful model to study the cardiovascular effects of anesthetics.
Assuntos
Anestésicos Inalatórios/farmacologia , Halotano/farmacologia , Hemodinâmica/efeitos dos fármacos , Isoflurano/farmacologia , Anestésicos Inalatórios/farmacocinética , Animais , Aorta/efeitos dos fármacos , Aorta/fisiologia , Artérias/efeitos dos fármacos , Embrião de Galinha , Halotano/farmacocinética , Frequência Cardíaca/efeitos dos fármacos , Fluxo Sanguíneo Regional/efeitos dos fármacos , Volume Sistólico/efeitos dos fármacos , Função Ventricular/efeitos dos fármacosRESUMO
This study investigated the phenomenon of ultrasonically induced lung hemorrhage in humans. Multiple experimental laboratories have shown that diagnostic ultrasound exposure can cause hemorrhage in the lungs of laboratory animals. The left lung of 50 patients (6 women, 44 men, mean age 61 years) was observed directly by the surgeon after routine intraoperative transesophageal echocardiography was performed. From manufacturer specifications the maximum derated intensity in the sound field of the system used was 186 W/cm2, the maximum derated rarefactional acoustic pressure was 2.4 MPa, and the maximum mechanical index was 1.3. The lowest frequency used was 3.5 MHz. This exposure exceeds the threshold found for surface lung hemorrhage seen on gross observation of laboratory animals. No hemorrhage was noted on any lung surface by the surgeon on gross observation. We conclude that clinical transesophageal echocardiography, even at field levels a little greater than the reported thresholds for lung hemorrhage in laboratory animals, did not cause surface lung hemorrhage apparent on gross observation. These negative results support the conclusion that the human lung is not markedly more sensitive to ultrasound exposure than that of other mammals.